Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Remme

Showing results (131-140 of 236) with videos related to

Pageof 24
Sort By:
American Heart Journal|May 4, 2010
Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA studyMichel E Bertrand, Roberto Ferrari, Wilhelm J Remme, et al.
The Journal of Infectious Diseases|May 1, 1992
Onchocerca volvulus DNA probe classification correlates with epidemiologic patterns of blindnessP A Zimmerman, K Y Dadzie, G De Sole, et al.
European Heart Journal|October 31, 1998
The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA)K M Fox, J R Henderson, M E Bertrand, et al.
American Heart Journal|March 27, 2007
Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery diseaseKim M Fox, Michel E Bertrand, Willem J Remme, et al.
Expert Review of Cardiovascular Therapy|November 27, 2007
Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trialRoberto Ferrari, Michel E Bertrand, Willem J Remme, et al.
The New England Journal of Medicine|September 2, 1999
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study InvestigatorsB Pitt, F Zannad, W J Remme, et al.
Bulletin of the World Health Organization|January 1, 1991
Onchocerciasis distribution and severity in five West African countriesG De Sole, R Baker, K Y Dadzie, et al.
European Heart Journal|April 30, 2005
The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudyCaroline A Daly, Kim M Fox, Willem J Remme, et al.
European Heart Journal|July 1, 1994
Long-term efficacy and safety of pimobendan in moderate heart failure. A double-blind parallel 6-month comparison with enalapril. The Pimobendan-Enalapril Study GroupW J Remme, H P Krayenbühl, G Baumann, et al.
European Heart Journal|September 1, 1987
Acute antiischaemic properties of high dosages of intravenous diltiazem in humans in relation to its coronary and systemic haemodynamic effectsW J Remme, D C van Hoogenhuyze, A Hofman, et al.
Pageof 24

Showing results (131-140 of 236) with videos related to

Sort By:
Pageof 24
American Heart Journal|May 4, 2010
Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA studyMichel E Bertrand, Roberto Ferrari, Wilhelm J Remme, et al.
The Journal of Infectious Diseases|May 1, 1992
Onchocerca volvulus DNA probe classification correlates with epidemiologic patterns of blindnessP A Zimmerman, K Y Dadzie, G De Sole, et al.
European Heart Journal|October 31, 1998
The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA)K M Fox, J R Henderson, M E Bertrand, et al.
American Heart Journal|March 27, 2007
Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery diseaseKim M Fox, Michel E Bertrand, Willem J Remme, et al.
Expert Review of Cardiovascular Therapy|November 27, 2007
Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trialRoberto Ferrari, Michel E Bertrand, Willem J Remme, et al.
The New England Journal of Medicine|September 2, 1999
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study InvestigatorsB Pitt, F Zannad, W J Remme, et al.
Bulletin of the World Health Organization|January 1, 1991
Onchocerciasis distribution and severity in five West African countriesG De Sole, R Baker, K Y Dadzie, et al.
European Heart Journal|April 30, 2005
The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudyCaroline A Daly, Kim M Fox, Willem J Remme, et al.
European Heart Journal|July 1, 1994
Long-term efficacy and safety of pimobendan in moderate heart failure. A double-blind parallel 6-month comparison with enalapril. The Pimobendan-Enalapril Study GroupW J Remme, H P Krayenbühl, G Baumann, et al.
European Heart Journal|September 1, 1987
Acute antiischaemic properties of high dosages of intravenous diltiazem in humans in relation to its coronary and systemic haemodynamic effectsW J Remme, D C van Hoogenhuyze, A Hofman, et al.
Pageof 24